|
MechanismEnvelope (E) protein inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Kineta SA
0 Patents (Medical) associated with Kineta SA
100 Deals associated with Kineta SA
100 Translational Medicine associated with Kineta SA